monsanto

Much more research is needed to understand the impact on human health of chronic dietary exposures to pesticides, many say.
American business is at risk of plunging into a race to the bottom.
Glyphosate has been touching the environment and public health in vast quantities for decades.
German drugmaker Bayer is the buyer.
The widely reviled seed and pesticide giant thinks it's worth more money.
Monsanto, which said last week it had a received an approach from Bayer but gave no details, has yet to comment on the offer.
The agricultural giant seems like it "forgot to sacrifice a goat to the gods."
Any deal could raise U.S. antitrust concerns because of the overlap in the seeds business.